Sulfinpyrazone in the Prevention of Sudden Death after Myocardial Infarction
- 31 January 1980
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 302 (5) , 250-256
- https://doi.org/10.1056/nejm198001313020502
Abstract
We report the results of a randomized, double-blind, multicenter trial comparing sulfinpyrazone (200 mg four times a day) and a placebo in the prevention of cardiac mortality among 1558 patients followed for an average of 16 months, beginning 25 to 35 days after a documented myocardial infarction.Keywords
This publication has 10 references indexed in Scilit:
- Risk stratification after acute myocardial infarctionThe American Journal of Cardiology, 1978
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital dischargeThe American Journal of Medicine, 1975
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974
- Marginal likelihoods based on Cox's regression and life modelBiometrika, 1973
- CORONARY PROGNOSTIC INDEX FOR PREDICTING SURVIVAL AFTER RECOVERY FROM ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1970
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970
- Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters.American Journal of Public Health and the Nations Health, 1968
- Immediate Mortality and Five-Year Survival of Employed Men with a First Myocardial InfarctionNew England Journal of Medicine, 1964
- Initial myocardial infarction among 503 VeteransThe American Journal of Medicine, 1960